• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Drug Companies Oppose Moves to Reimburse Off-Label Medicine

    Drug Companies Oppose Moves to Reimburse Off-Label Medicine

  2. AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

    AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

  3. Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

    Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

  4. MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX

    MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX

  5. Bayer and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed

    Bayer and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed

  6. Reckitt Benckiser Plans to Divest Its U.S. Pharma Division -- Report

    Reckitt Benckiser Plans to Divest Its U.S. Pharma Division -- Report

  7. Greenlight Notes Short Positions in Safeway, Lorillard -Reuters

    Greenlight Notes Short Positions in Safeway, Lorillard -Reuters

  8. Morningstar's Most Popular

    Our most popular articles and videos for the week ended July 25.

  9. Research and Markets: Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon

    Research and Markets: Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon

  10. What Makes a Moat?

    In an excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins explore how to identify a moat and how intangible assets can help a firm carve out a sustainable competitive advantage.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.